デフォルト表紙
市場調査レポート
商品コード
1002728

結核診断の世界市場:テストタイプ別、タイプ別、エンドユーザー別の市場調査、予測(~2026年)、COVID-19の累積的な影響

Tuberculosis Diagnostics Market Research Report by Test Type, by Type, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.81円
結核診断の世界市場:テストタイプ別、タイプ別、エンドユーザー別の市場調査、予測(~2026年)、COVID-19の累積的な影響
出版日: 2021年06月01日
発行: 360iResearch LLP
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の結核診断の市場規模は、2020年の25億9,177万米ドルから、2025年末までに32億2,308万米ドルに成長すると予想されています。

市場セグメンテーションとカバレッジ

この調査レポートは、結核診断の世界市場を分類して、収益を予測し、次の各サブマーケットの動向を分析します。

テストタイプ別では、市場は、薬剤感受性テスト、ラボラトリー方法、マントーテスト、核酸テスト、およびX線撮影方法にわたって調査されました。

タイプ別では、市場は、ポイントオブケア技術と迅速テストで調査されました。

エンドユーザー別では、市場は、診断研究所と病院および診療所にわたって調査されました。

アジア太平洋地域は、予測期間中に最高の成長を目にすると予測されています。

地域別では、市場は、南北アメリカ、アジア太平洋、および欧州と中東・アフリカに分けて調査されました。南北アメリカ地域はアルゼンチン、ブラジル、カナダ、メキシコ、および米国。アジア太平洋地域はオーストラリア、中国、インド、インドネシア、日本、マレーシア、フィリピン、韓国、タイ。欧州と中東およびアフリカ地域は、フランス、ドイツ、イタリア、オランダ、カタール、ロシア、サウジアラビア、南アフリカ、スペイン、アラブ首長国連邦、および英国において調査されました。欧州、中東・アフリカは2020年に結核診断市場で最大の規模を示しました。一方、アジア太平洋地域は予測期間中に最速のCAGRで成長すると予想されます。

企業のユーザビリティプロファイル

当レポートはAbbott Laboratories, ACON DIABETES CARE, Alere, Inc., Becton, Dickinson, and Company, BioMerieux SA, Boson Biotech Co., Ltd., CapitalBio Technology, Cepheid Inc., Elisabeth Pharmacon spol, ELITech Group, F. Hoffmann-La Roche AG, Firstep Bioresearch, Inc., Hain Lifescience GmbH, Hologic Corporation, Medical Innovation Ventures, OSANG Healthcare, Oxford Immunotec Ltd., RTA Laboratories, Siemens AG, Standard Diagnostics, Thermo Fisher Scientific, Inc., and Turklab Tibbi Malzemeler Sanなど、世界市場における主要ベンダーによる最近の重要な進展とイノベーションプロファイルを深く探求しています。

COVID-19の累積的影響

COVID-19は、ほぼすべての業界に影響を与えた比類のない世界的な公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されます。私たちの進行中の調査は、調査フレームワークを増幅して、基礎となるCOVID-19の問題と今後の潜在的な道筋を確実に含めるようにしています。調査は消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場の力のダイナミクス、および政府の重要な介入を考慮した、COVID-19に関する洞察を提供しています。更新された調査は、市場へのCOVID-19の影響を考慮して、洞察、分析、推定、および予測を提供します。

 

当レポートでは結核診断の世界市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、市場機会、COVID-19の影響、テストタイプ・タイプ・エンドユーザー・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査のために考慮された年
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査デザイン
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画の作成
    • 実行:調査の実施
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • 市場の見通し
  • テストタイプの見通し
  • エンドユーザーの見通し
  • タイプの見通し
  • 地域の見通し
  • 競合他社の見通し

第4章 市場概要

  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターズのファイブフォース分析
    • 新規参入業者の脅威
    • 代替品の脅威
    • 顧客の交渉力
    • 供給企業の交渉力
    • 業界の競争

第6章 テストタイプ別

  • 薬剤感受性テスト
  • ラボラトリー方法
  • マントーテスト
  • 核酸テスト
  • X線撮影法

第7章 タイプ別

  • ポイントオブケア技術
  • 迅速テスト

第8章 エンドユーザー別

  • 診断調査
  • 病院と診療所

第9章 南北アメリカ

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第11章 欧州、中東・アフリカ

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 契約、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 賞、表彰、拡大

第13章 企業のユーザビリティプロファイル

  • Abbott Laboratories
  • ACON DIABETES CARE
  • Alere, Inc.
  • Becton, Dickinson, and Company
  • BioMerieux SA
  • Boson Biotech Co., Ltd.
  • CapitalBio Technology
  • Cepheid Inc.
  • Elisabeth Pharmacon spol
  • ELITech Group
  • F. Hoffmann-La Roche AG
  • Firstep Bioresearch, Inc.
  • Hain Lifescience GmbH
  • Hologic Corporation
  • Medical Innovation Ventures
  • OSANG Healthcare
  • Oxford Immunotec Ltd.
  • RTA Laboratories
  • Siemens AG
  • Standard Diagnostics
  • Thermo Fisher Scientific, Inc.
  • Turklab Tibbi Malzemeler San

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2026
  • FIGURE 11. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG-SUSCEPTIBILITY TESTING, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG-SUSCEPTIBILITY TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY LABORATORY METHODS, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY LABORATORY METHODS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MANTOUX TEST, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MANTOUX TEST, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY RADIOGRAPHIC METHODS, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY RADIOGRAPHIC METHODS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 22. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2026
  • FIGURE 24. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TECHNOLOGIES, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TECHNOLOGIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2026 (USD MILLION)
  • FIGURE 27. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2020 VS 2026 (%)
  • FIGURE 29. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2026
  • FIGURE 31. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS RESEARCH LABORATORY, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS RESEARCH LABORATORY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINICS, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 36. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 38. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. CALIFORNIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. FLORIDA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. ILLINOIS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. NEW YORK TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. OHIO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. PENNSYLVANIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. TEXAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 51. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 53. CHINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. INDIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. INDONESIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. JAPAN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. MALAYSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. PHILIPPINES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. SOUTH KOREA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. THAILAND TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 62. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 64. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. ITALY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. NETHERLANDS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. QATAR TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. SAUDI ARABIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. SOUTH AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. SPAIN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. UNITED ARAB EMIRATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 76. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 77. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG-SUSCEPTIBILITY TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY LABORATORY METHODS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MANTOUX TEST, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY RADIOGRAPHIC METHODS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TECHNOLOGIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS RESEARCH LABORATORY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. CALIFORNIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. CALIFORNIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. CALIFORNIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. FLORIDA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. FLORIDA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. FLORIDA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. ILLINOIS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ILLINOIS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. ILLINOIS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. NEW YORK TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. NEW YORK TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. NEW YORK TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. OHIO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. OHIO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. OHIO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. PENNSYLVANIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. PENNSYLVANIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. PENNSYLVANIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. TEXAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. TEXAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. TEXAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. CHINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. CHINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. CHINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. INDIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. INDIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. INDIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. INDONESIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. INDONESIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. INDONESIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. JAPAN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. JAPAN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. JAPAN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. MALAYSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. MALAYSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. MALAYSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. PHILIPPINES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. PHILIPPINES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. PHILIPPINES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. SOUTH KOREA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. SOUTH KOREA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. SOUTH KOREA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. THAILAND TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. THAILAND TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. THAILAND TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. ITALY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. ITALY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. ITALY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. NETHERLANDS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. NETHERLANDS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. NETHERLANDS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. QATAR TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. QATAR TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. QATAR TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. SAUDI ARABIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. SAUDI ARABIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. SAUDI ARABIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. SOUTH AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SOUTH AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SOUTH AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. SPAIN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. SPAIN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. SPAIN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. UNITED ARAB EMIRATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. UNITED ARAB EMIRATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. UNITED ARAB EMIRATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: SCORES
  • TABLE 122. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: BUSINESS STRATEGY
  • TABLE 123. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: PRODUCT SATISFACTION
  • TABLE 124. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: RANKING
  • TABLE 125. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 126. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 127. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: MERGER & ACQUISITION
  • TABLE 128. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 129. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 130. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: INVESTMENT & FUNDING
  • TABLE 131. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 132. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: LICENSE & PRICING
  • TABLE 133. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: CONTACT DETAILS
目次
Product Code: MRR-03252A5F9275

The Global Tuberculosis Diagnostics Market size was estimated at USD 2,591.77 Million in 2020 and expected to reach USD 2,720.23 Million in 2021, at a Compound Annual Growth Rate (CAGR) 5.29% to reach USD 3,532.13 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Tuberculosis Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Test Type, the Tuberculosis Diagnostics Market was studied across Drug-susceptibility Testing, Laboratory Methods, Mantoux Test, Nucleic Acid Testing, and Radiographic Methods.

Based on Type, the Tuberculosis Diagnostics Market was studied across Point-of-care Technologies and Rapid test.

Based on End_User, the Tuberculosis Diagnostics Market was studied across Diagnostics Research Laboratory and Hospital & Clinics.

Based on Geography, the Tuberculosis Diagnostics Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Tuberculosis Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Tuberculosis Diagnostics Market, including Abbott Laboratories, ACON DIABETES CARE, Alere, Inc., Becton, Dickinson, and Company, BioMerieux SA, Boson Biotech Co., Ltd., CapitalBio Technology, Cepheid Inc., Elisabeth Pharmacon spol, ELITech Group, F. Hoffmann-La Roche AG, Firstep Bioresearch, Inc., Hain Lifescience GmbH, Hologic Corporation, Medical Innovation Ventures, OSANG Healthcare, Oxford Immunotec Ltd., RTA Laboratories, Siemens AG, Standard Diagnostics, Thermo Fisher Scientific, Inc., and Turklab Tibbi Malzemeler San.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Tuberculosis Diagnostics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Tuberculosis Diagnostics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Tuberculosis Diagnostics Market?
  • 4. What is the competitive strategic window for opportunities in the Global Tuberculosis Diagnostics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Tuberculosis Diagnostics Market?
  • 6. What is the market share of the leading vendors in the Global Tuberculosis Diagnostics Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Tuberculosis Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Test Type Outlook
  • 3.4. End_User Outlook
  • 3.5. Type Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing burden of tuberculosis globally and need to diagnose at very early stage
      • 5.1.1.2. Increasing R&D investments and intensive diagnostics products in pipelines
      • 5.1.1.3. Supportive government initiatives and rising awareness in the emerging markets
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with tuberculosis diagnostics
      • 5.1.2.2. Limited reimbursement options
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising number of government awareness programs
      • 5.1.3.2. Advancement in the diagnostics procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Low coverage or absence of insurance in emerging markets
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Tuberculosis Diagnostics Market, by Test Type

  • 6.1. Introduction
  • 6.2. Drug-susceptibility Testing
  • 6.3. Laboratory Methods
  • 6.4. Mantoux Test
  • 6.5. Nucleic Acid Testing
  • 6.6. Radiographic Methods

7. Tuberculosis Diagnostics Market, by Type

  • 7.1. Introduction
  • 7.2. Point-of-care Technologies
  • 7.3. Rapid test

8. Tuberculosis Diagnostics Market, by End_User

  • 8.1. Introduction
  • 8.2. Diagnostics Research Laboratory
  • 8.3. Hospital & Clinics

9. Americas Tuberculosis Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Tuberculosis Diagnostics Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Tuberculosis Diagnostics Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Abbott Laboratories
  • 13.2. ACON DIABETES CARE
  • 13.3. Alere, Inc.
  • 13.4. Becton, Dickinson, and Company
  • 13.5. BioMerieux SA
  • 13.6. Boson Biotech Co., Ltd.
  • 13.7. CapitalBio Technology
  • 13.8. Cepheid Inc.
  • 13.9. Elisabeth Pharmacon spol
  • 13.10. ELITech Group
  • 13.11. F. Hoffmann-La Roche AG
  • 13.12. Firstep Bioresearch, Inc.
  • 13.13. Hain Lifescience GmbH
  • 13.14. Hologic Corporation
  • 13.15. Medical Innovation Ventures
  • 13.16. OSANG Healthcare
  • 13.17. Oxford Immunotec Ltd.
  • 13.18. RTA Laboratories
  • 13.19. Siemens AG
  • 13.20. Standard Diagnostics
  • 13.21. Thermo Fisher Scientific, Inc.
  • 13.22. Turklab Tibbi Malzemeler San

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details